Walgreens remains focused on clinical trials despite CVS exit

Walgreens is doubling down on clinical trials after competitor CVS Health said it would be exiting that market by the end of 2024, Yahoo Finance reported.

Advertisement

Retailers began launching research institutes during the pandemic to get access to more diverse study participants. However, CVS said May 15 it would be winding down its clinical trial business to focus on its “long-term strategic priorities.”

“We are full steam ahead as we continue to support many of our manufacturers that have come into the ecosystem since June,” Ramita Tandon, chief clinical trials officer at Walgreens, told Yahoo Finance in the May 15 story. “We’re very focused on what we’re doing at Walgreens because it’s part of the broader healthcare mission and journey that we’re on.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.